|
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev, Yu.Yu. Vinnik
An observational randomized study of the efficacy and safety of the drug Longidase®, vaginal and rectal suppositories 3000 iu in the treatment of patients with symptoms of the lower urinary tract on the background of benign prostatic hyperplasia
|
№6 / 2021
|
|
S.V. Kotov, A.D. Bolotov, S.V. Belomyttsev,
D.N. Surenkov, A.V. Vorobyova
Multicenter randomized study
of bovhyalu-ronidase azoximer (Longidaza®)
in men after transuretral resection
of the prostate
|
№3 / 2021
|
|
E.V. Kulchavenya, E.V. Brijatuk, D.P. Kholtobin, A.G. Cherednichenko
Current approach to diagnosis of chronic prostatitis
|
№2 / 2021
|
|
A.I. Neumark, B.A. Neymark, N.A. Nozdrachev, V.M. Bryukhanov, A.Yu. Plotnikova, D.A. Podpruzhnikova, A.A. Nikulina
The influence of proteolytic enzymes on the antioxidant defensive system in infertile married men
|
№4 / 2019
|
|
E.V. Kulchavenya, O.P. Shvetsova, A.A. Breusov
Rationale of use and effectiveness of Longidaza in patients with chronic prostatitis
|
№4 / 2018
|
|
A.V. Zaitsev, D.Yu. Pushkar, L.A. Khodyreva, A.A. Dudareva
Bacterial prostatitis and prostatic fibrosis: modern view on the treatment and prophylaxis
|
№4 / 2016
|
|
D.G. Pochernikov, E.Yu. Vinokurov, A.I. Strelnikov, L.V. Yakovleva
Experience in the treatment of autoimmune male infertility in patients with category 4 chronic prostatitis
|
№6 / 2014
|
Русский
